Context Capital Management’s Cardio Diagnostics CDIO Stock Holding History

Context Capital Management’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-543	Closed	-$17K	–	342
2022 Q4	$17K	Sell	543 -7,790	-93%	-$841K	﹤0.01%	290
2022 Q3	$2.51M	Hold	8,333	–	–	0.17%	177
2022 Q2	$2.49M	Hold	8,333	–	–	0.18%	175
2022 Q1	$2.47M	Buy	+8,333	New	+$2.46M	0.16%	188

Other funds holding CDIO

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Context Capital Management's CDIO Position: Q1 2023 in Review

Context Capital Management sold out of Cardio Diagnostics (CDIO) in Q1 2023, closing a stake of 543 shares — an estimated $17K sold.

Context Capital Management first reported a position in CDIO in Q1 2022 and held it in 4 quarters. The position peaked at $2.51M in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q1 2023.

Context Capital Management reported no remaining Cardio Diagnostics position as of Q1 2023 after selling out during the quarter.
Context Capital Management sold 543 Cardio Diagnostics shares in Q1 2023, an estimated $17K.
Context Capital Management first reported a position in Cardio Diagnostics in Q1 2022 and held it in 4 quarters.
Context Capital Management's Cardio Diagnostics position peaked at $2.51M in Q3 2022.
11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2023.

Based on Context Capital Management's 13F filing for Q1 2023, filed 8 May 2023.